Improving the enrichment of mononuclear cells for CAR T cell therapies: the importance of platelet depletion

Watch the video or read the poster to learn:

• Why optimal mononuclear cell enrichment is critical to the successful start of a standard autologous CAR-T manufacturing process
• How a platelet removal step upstream rather than downstream of density gradient separation can reduce the amount of red blood cell contamination
• Working with a closed and automated system for both platelet removal and density gradient separation minimizes the risk of contamination, operator variability, and errors, while also reducing procedure time

Please enter your email to access content Read now